Bipartisan drug shortage legislation is gaining traction in the US as coronavirus outbreak begins disrupting the pharmaceutical supply chain: There is a new bill in the House and growing stakeholder support for both the House bill and companion legislation that had been languishing in the Senate.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?